ESMO Preceptorship on Lung Cancer 2016

Oncology Meeting Resources

03 Feb - 05 Feb, Manchester, United Kingdom

ESMO Preceptorship on Lung Cancer

The ESMO Preceptorship on Lung Cancer 2016 focused on enabling participants to learn about the evidence-base for lung cancer screening and novel diagnostic modalities, learn about the management of early stage NSCLC and use of adjuvant treatments, understand the role of multi-modality treatment in locally advanced NSCLC and limited stage SCLC, learn about the management of patients with actionable driver Mutations and novel targeted agents for advanced NSCLC, understand the role of immuno-checkpoint blockade for lung cancer and learn about novel immunotherapies, learn about treatment of NSCLC with oligometastatic disease, learn about the systemic treatment of mesothelioma and small-cell lung cancer and integrating palliative care  in lung cancer treatment.

Webcasts from the ESMO Preceptorship on Lung Cancer 2016 are now available here. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Presenter Presentation title Session title
Richard Booton EBUS TBNA in diagnosis/staging of lung cancer Screening and Diagnostic for Lung Cancer
Mo Al Aloul Medical Thoracoscopy in the management of thoracic malignancies Screening and Diagnostic for Lung Cancer
Rohit Kochhar PET/CT in staging of lung cancer Screening and Diagnostic for Lung Cancer
Keith Kerr Role of pathologist in diagnosis and mutation analysis of lung cancer Screening and Diagnostic for Lung Cancer
Paul Taylor Adjuvant chemotherapy for completely resected early stage NSCLC Radical treatment of early stage NSCLC
Cécile Le Pechoux Adjuvant radiotherapy for completely resected early stage NSCLC Radical treatment of early stage NSCLC
Suresh Senan Stereotactic ablative RT for early stage NSCLC Radical treatment of early stage NSCLC
Dominique Grunenwald Surgery for early stage NSCLC Radical treatment of early stage NSCLC
Rolf Stahel Systemic Treatment of Mesothelioma Radical treatment of early stage NSCLC
Federico Cappuzzo Beyond ALK and EGFR: Novel molecularly driven targeted therapies in NSCLC Advanced NSCLC
Jean-Yves Douillard First-line chemotherapy for advanced NSCLC Advanced NSCLC
Yvonne Summers Maintenance treatment for advanced NSCLC Advanced NSCLC
Marina Garassino Second-line treatment for advanced NSCLC Advanced NSCLC
Raffaele Califano Treatment of EGFR mutant advanced NSCLC Advanced NSCLC
Miklos Pless Immunotherapy for lung cancer Palliative Treatment of Lung Cancer and Mesothelioma